SeaBeLife: Biotech startup SeaBeLife picks up Euro 1.4 million
SeaBeLife is a biotech startup developing drug candidates to block cell necrosis. Today, it's announced a funding boost of almost Euro 1.4 million financing from Bpifrance.
Read full article »
SeaBeLife is a France-based biotechnology company that researches and develops small molecules for the treatment of regulated necrosis.
Read more